NOMINATION PERIOD OPEN FOR THE AACR DANIEL D. VON HOFF AWARD
Philadelphia, PA, March 2022 – The American Association for Cancer Research (AACR) is currently accepting nominations for the AACR Daniel D. Von Hoff Award, named after Stromatis Pharma’s founder Dr. Daniel D. Von Hoff. Stromatis Pharma is a private biotech company located in Prince William County’s Innovation Park, VA. Stromatis is committed to developing therapeutics […]
STROMATIS PHARMA AND CAERUS THERAPEUTICS ANNOUNCE A LICENSING DEAL
Manassas, Virginia – Stromatis Pharma announces an exciting deal with Caerus Therapeutics, allowing Stromatis Pharma exclusive rights to utilize Caerus Therapeutics’ innovative and proprietary antibody-discovery platform for the discovery of ten novel antibodies. Caerus Therapeutics’ platform, referred to as Differential Immunization for Antibody and Antigen Discovery (DIAAD), is combined with a synthetic lymph node mimetic […]
